SARS CoV-2 (COVID-19) Current Pharmacotherapy for Mother and Infant.
Neonatal Netw
; 40(3): 175-182, 2021 May 01.
Article
in English
| MEDLINE | ID: covidwho-1259287
ABSTRACT
The novel coronavirus disease 2019 (COVID-19), appeared in the United States over 1 year ago. This virus has a wide range of presentations, from being asymptomatic to causing severe acute respiratory syndrome, which can lead to death. It has led to a worldwide effort to find effective treatments, from repurposed medications to new discoveries, as well as the push to develop effective vaccines. As the race to fight this pandemic unfolds, this column provides what is currently available to combat this virus, how it has been utilized in the pregnant population, and what data have been made available about how these treatments affect fetal development and the neonate.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Neonatal Nursing
/
Infectious Disease Transmission, Vertical
/
Severe Acute Respiratory Syndrome
/
COVID-19
/
COVID-19 Drug Treatment
/
Maternal Health Services
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Adult
/
Female
/
Humans
/
Male
/
Infant, Newborn
Country/Region as subject:
North America
Language:
English
Journal:
Neonatal Netw
Journal subject:
Nursing
/
Perinatology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS